Form 4: Pfizer CEO Albert Bourla Reports Acquisition of Phantom Stock Units
SEC Form 4 Filing
Pfizer's CEO, Albert Bourla, reported the acquisition of 75 phantom stock units through the Pfizer Supplemental Savings Plan on January 13, 2025.
Summary
- On January 13, 2025, Albert Bourla, the Chairman & CEO of Pfizer Inc., acquired 75 phantom stock units.
- The acquisition was made through the Pfizer Supplemental Savings Plan (SSP).
- Each unit represents one phantom share of common stock.
- These units are settled in cash following the reporting person's separation from service and may be transferred into an alternative investment account at any time.
- Following the transaction, Bourla directly owns 690,650 shares of Pfizer common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction indicating the CEO's continued investment in the company through a standard compensation plan.
Positives
- The acquisition of phantom stock units aligns the CEO's interests with those of the shareholders.
Future Outlook
The document does not contain any specific forward-looking statements regarding Pfizer's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates that the CEO is accumulating more phantom stock units, which is a common practice for executive compensation.
Comparison to Industry Standards
- Executive compensation packages often include phantom stock units as a way to align executive incentives with shareholder value.
- Companies like Johnson & Johnson (JNJ) and Merck & Co. (MRK) also utilize similar compensation strategies for their executives.
- The amount of phantom stock units granted to executives varies depending on the company's size, performance, and compensation philosophy.
Stakeholder Impact
- The acquisition of phantom stock units by the CEO can be viewed positively by shareholders as it aligns management's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 01/13/2025 | Date of transaction: Acquisition of phantom stock units. |
| 01/15/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.